Voglibose 0.3mg + Glimepiride 1mg + Metformin Hydrochloride 500mg (SR) Bilayerd 

Type 2 diabetes mellitus treatment can be achieved using a bilayer tablet consisting of Voglibose 0.3mg + Glimepiride 1mg + Metformin Hydrochloride 500mg (SR) Bilayerd  (BOSESAP GM FORTE 1 ). Individual components of the combination drive and come together for blood glucose control by different mechanisms.

Uses

• This medication combination is prescribed to those suffering from type 2 diabetes, especially if more than one drug is required to establish glycemic control. It maintains the patient’s blood sugar levels within the desired ranges and reduces complications from the disease.

Components and Mechanism of Action of BOSESAP GM FORTE 1

1. Voglibose (0.3mg):
   • Class: Alpha-Glucosidase Inhibitor.
   • Action: Voglibose works by inhibiting the enzyme alpha-glucosidase in the intestines, which delays the absorption of carbohydrates. This helps in preventing a sharp rise in blood glucose levels after meals.
2. Glimepiride (1mg):
   • Class: Sulfonylurea.
   • Action: Glimepiride stimulates the release of insulin from the pancreatic beta cells. Increased insulin levels help lower blood glucose levels.
3. Metformin Hydrochloride (500mg SR – Sustained Release):
   • Class: Biguanide.
   • Action: Metformin decreases glucose production in the liver, improves insulin sensitivity, and enhances peripheral glucose uptake. The sustained-release formulation helps maintain steady blood levels of the medication, providing a prolonged effect.